Impaired IL-7 signaling may explain a case of atypical JAK3-SCID
- PMID: 19889552
- DOI: 10.1016/j.cyto.2009.09.009
Impaired IL-7 signaling may explain a case of atypical JAK3-SCID
Abstract
Janus kinase 3-severe combined immunodeficiency (JAK3-SCID) is an autosomal recessive immunodeficiency disease caused by various mutations in the JAK3 gene. Typical JAK3-SCID is characterized by a phenotype in which B cells are present but T and NK cells are not, the T(-)B(+)NK(-) phenotype, and by impaired signaling through cytokine receptors that use the common gamma chain (gammac) subunit. An atypical JAK3-SCID case carrying a single glutamate to glycine substitution mutation (E481G) in the JH3 domain of one JAK3 allele, and a deletion mutation (del482-596) in the JH3 and JH2 domains of the other allele was reported previously. Although this patient had CD4(+) T cells and NK cells unlike typical cases, the CD4(+) T cells were functionally impaired. We report here that the JAK3-E481G mutant transduced IL-2-, IL-4-, IL-15-, and IL-21-induced signals as efficiently as wild-type JAK3. However, this mutant failed to respond to IL-7 by phosphorylating JAK1, JAK3, or STAT5. The other mutant JAK3, JAK3-del482-596, was non-functional. Thus, an impaired IL-7 signal may cause SCID and compromise T-cell differentiation, even if the IL-15 signal is preserved and supports NK-cell development, as in this patient.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.Nat Genet. 1998 Dec;20(4):394-7. doi: 10.1038/3877. Nat Genet. 1998. PMID: 9843216
-
X-linked SCID and other defects of cytokine pathways.Semin Hematol. 1998 Oct;35(4):299-309. Semin Hematol. 1998. PMID: 9801259 Review.
-
IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.J Allergy Clin Immunol. 2003 Dec;112(6):1033-45. doi: 10.1016/j.jaci.2003.08.039. J Allergy Clin Immunol. 2003. PMID: 14657853 Review.
-
Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors.Chem Biol. 2011 Mar 25;18(3):314-23. doi: 10.1016/j.chembiol.2011.01.012. Chem Biol. 2011. PMID: 21439476
-
A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.Hum Mutat. 2004 May;23(5):522-3. doi: 10.1002/humu.9235. Hum Mutat. 2004. PMID: 15108287
Cited by
-
IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3).FEBS Lett. 2011 Jan 3;585(1):159-66. doi: 10.1016/j.febslet.2010.11.031. Epub 2010 Nov 21. FEBS Lett. 2011. PMID: 21095188 Free PMC article.
-
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.Target Oncol. 2012 Mar;7(1):55-68. doi: 10.1007/s11523-012-0210-4. Epub 2012 Mar 2. Target Oncol. 2012. PMID: 22383042 Free PMC article. Review.
-
Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3).J Mol Biol. 2011 May 20;408(5):850-62. doi: 10.1016/j.jmb.2011.03.017. Epub 2011 Mar 22. J Mol Biol. 2011. PMID: 21414324 Free PMC article.
-
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.J Allergy Clin Immunol. 2013 Apr;131(4):1136-45. doi: 10.1016/j.jaci.2012.12.667. Epub 2013 Feb 4. J Allergy Clin Immunol. 2013. PMID: 23384681 Free PMC article.
-
Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.Medicine (Baltimore). 2017 Oct;96(42):e7989. doi: 10.1097/MD.0000000000007989. Medicine (Baltimore). 2017. PMID: 29049190 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
